- Nov 20
Next generation T-cell engineering with ArsenalBio
Co-founder, Chairman & CEO Ken Drazan explains the array of applications that Arsenal engineers into its CAR-T cells.
- Nov 15
An exclusive look at the Cellares Cell Shuttle automated cell therapy manufacturing system
CEO Fabian Gerlinghaus shares a business overview and VP of R&D Daniele Malleo gives a hands on tour of how the Cell Shuttle works.
- Nov 6
Visiting Scripps Research Part 2: Coronavirus and HIV research, and state of the art cryo-EM
Andrew Ward describes the foundational research Scripps has made regarding coronavirus and HIV research.
- Nov 6
Visiting Scripps Research Part 1: Translational research & high throughput screening at Calibr
Travis Young explains the idea behind Calibr and describes a switchable CAR-T program that has been developed there.
- Oct 31
Talking allo CAR-T and seeing how it is manufactured at Poseida
Kristin Yarema, CEO starting Jan 1st, describes Poseida's approach to allo CAR-T and then CMC expert Chad Headlee gives us a tour.
- Oct 6
Behind-the-scenes of base editing at Beam Therapeutics
CEO John Evans gives an update on Beam's pipeline and then we take a lab tour to see the science in action with President Pino Ciaramella.
- Sep 11
Hearing from experts in biomedical research while touring the Broad Discovery Center
Discussing rare disease, psychiatric research, infectious disease, and cancer with experts from the Broad Institute.
